期刊
BIOMATERIALS SCIENCE
卷 10, 期 2, 页码 499-513出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d1bm01520f
关键词
-
资金
- Program for Major Scientific and Medical Technology Problems of China Medicine Education Association in 2020 [2020KTS004]
- National Natural Science Foundation of China [81874347]
- Liaoning Natural Science Foundation [2019-MS-226]
- LiaoNing Revitalization Talents Program [XLYC1807132]
The folate-modified triptolide liposomes designed in this study showed specific targeting effects in treating RA and demonstrated low cytotoxicity and significant anti-inflammatory properties in vitro. In vivo experiments also indicated good cartilage protection and anti-inflammatory effects with lower toxicity compared to free triptolide, providing a promising new approach for RA treatment.
Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial joint hyperplasia, joint inflammation, cartilage erosion and bone destruction. Macrophages play an essential role in the pathogenesis of RA, and folate receptor beta (FR-beta) is highly expressed on the surface of activated synovial macrophages in RA patients. Triptolide (TP) has anti-inflammatory properties, and it can protect the cartilage matrix, but its clinical application has been limited due to poor solubility, low bioavailability and systemic toxicity. Therefore, we constructed folate-modified triptolide liposomes (FA-TP-Lips) to target macrophages, thereby treating RA in a safe and effective way. The experiments indicated that FA-TP-Lips had properties of small particle size, uniform particle size distribution, high drug encapsulation and long circulation. Furthermore, FA-TP-Lips showed reduced cytotoxicity, increased cellular uptake and significant anti-inflammatory effects in vitro. It also inhibited osteoclastogenesis. In vivo experiments revealed that liposomes could prolong the circulation of TP in the body, as well as exhibit significant cartilage-protective and anti-inflammatory effects with lower toxicity compared with the free TP group, thereby providing a promising new approach for the treatment of RA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据